Unnecessary Insulin Administered Without a Valid Indication
Summary
The facility failed to ensure that a resident’s drug regimen was free from unnecessary drugs when it administered insulin glargine to a resident who did not have a diagnosis or history of diabetes or blood glucose complications. The resident was admitted with diagnoses including bacterial pneumonia, hypertension, insomnia, major depressive disorder, and generalized anxiety disorder, and her MDS did not identify diabetes or any insulin use. Her care plan addressed anxiety and depression, but there were no care plan problems or interventions related to diabetes or insulin therapy. The resident’s medication record showed an order for Lantus Solostar U-100 Insulin, 10 units subcutaneously daily, entered with no diagnosis or indication for use. A second insulin glargine order also appeared in the record without a diagnosis or indication. The MAR showed that the resident received insulin on two separate days, while additional scheduled doses were refused. The psychiatric NP’s evaluation and follow-up notes reflected treatment for anxiety and depression, and the psychiatric provider reviewed the resident’s medications without any indication that insulin was part of her treatment plan. During interviews, the resident stated she was not diabetic and reported that after the second insulin injection she felt sleepy and believed the medication was an error. She also stated that her anxiety worsened after the incident and that she became concerned about receiving medications from nursing staff. The resident and her representative reported that the nurse did not check her blood sugar before giving the insulin. Facility staff acknowledged that the insulin order had been entered incorrectly and that the resident had received the medication despite lacking a diabetic diagnosis.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.